查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611416

睡眠輔助市場：依產品、睡眠障礙、通路 - 2025-2030 年全球預測

Sleep Aids Market by Product (Mattresses & Pillows, Medications, Sleep Apnea Devices), Sleep-Disorder (Insomnia, Narcolepsy, Restless Legs Syndrome), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年睡眠輔助市場的市場規模為593.2億美元，預計2024年將達到641.5億美元，複合年成長率為5.98%，到2030年將達到891.1億美元。

睡眠輔助市場包括各種旨在幫助個人獲得更好睡眠的產品和服務。此類別包括鎮靜劑和安眠藥等藥品、褪黑激素補充品等非處方藥以及智慧睡眠面罩和睡眠追蹤應用程式等設備。由於壓力和快節奏的生活方式會加劇失眠、睡眠呼吸中止症和其他睡眠障礙，因此需要助眠劑。其應用範圍從醫療機構、健康中心到個人家庭使用。最終用戶包括患有睡眠問題的成年人、面臨自然睡眠下降的老年人，甚至是受螢幕時間影響的青少年。睡眠重要性意識的提高、睡眠障礙發病率的上升以及睡眠技術的進步推動了市場的成長。然而，安眠藥依賴帶來的恥辱和對副作用的擔憂也起到了一定作用。草藥補充品和數位療法等自然和替代睡眠解決方案存在巨大機遇，這反映了國家向整體健康實踐的轉變。建議包括投資研究和開發非成癮性睡眠輔助工具和使用者友善的睡眠技術。市場面臨藥品監管嚴格、使用者需求多樣化、冥想、瑜珈等傳統療法的競爭等挑戰。創新已經成熟，包括用於更準確睡眠追蹤的生物感測器、人工智慧驅動的個人化睡眠解決方案以及結合多個健康指標資料的整合應用程式。市場動態是動態的，其特點是技術快速進步以及對無縫融入日常生活的安全有效解決方案的強烈偏好。為了利用這一不斷變化的格局，公司應專注於建立多功能產品線，以滿足尋求醫療和非醫療睡眠改善解決方案的不同消費者群體的需求。

主要市場統計
基準年[2023] 593.2億美元
預計年份 [2024] 641.5億美元
預測年份 [2030] 891.1億美元
複合年成長率（%） 5.98%

市場動態：快速發展的睡眠輔助市場的關鍵市場洞察

供需的動態交互作用正在改變睡眠輔助市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 對各種睡眠狀況的治療和​​診斷的需求不斷增加
    • 提高大眾對睡眠障礙的認知
    • 穿戴式感測器和追蹤設備的接受度不斷提高
  • 市場限制因素
    • 睡眠輔助設備校準不當
  • 市場機會
    • 助眠新科技介紹
    • 政府增加研發經費競標大型睡眠輔助設備
  • 市場挑戰
    • 缺乏適當的授權文件

波特的五力：駕馭睡眠輔助市場的策略工具

波特的五力框架是了解睡眠輔助市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解睡眠輔助市場的外部影響

外部宏觀環境因素在塑造助眠劑市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解睡眠輔助市場的競爭格局

對睡眠輔助市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣睡眠輔助市場供應商的績效評估

FPNV定位矩陣是評估睡眠輔助市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了睡眠輔助市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對睡眠輔助市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對各種睡眠障礙的治療和診斷的需求日益成長。
      • 提高大眾對睡眠障礙的認知
      • 穿戴式感測器和追蹤設備的採用增加
    • 抑制因素
      • 助眠器調整不當
    • 機會
      • 助眠新科技介紹
      • 政府對研發 (R&D) 的資助增加導致睡眠輔助產品的大舉競標
    • 任務
      • 缺乏授權許可所需的適當文件
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章睡眠輔助市場：依產品

  • 床墊和枕頭
  • 藥品
    • 草藥
    • 非處方藥
    • 處方藥
  • 睡眠呼吸中止症裝置
    • 自適應人工呼吸器伺服(ASV)
    • 臉部介面
    • 口腔矯正器
    • 正壓呼吸器(PAP)設備

第7章睡眠輔助市場睡眠障礙

  • 失眠
  • 發作性睡病
  • 不寧腿
  • 睡眠呼吸中止症
  • 夢遊

第8章睡眠輔助市場：按分銷管道

  • 藥局
  • 電子商務
  • 醫院藥房
  • 零售藥房

第9章美洲睡眠輔助市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太睡眠輔助市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的睡眠輔助市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Apnea Sciences Corporation
  • Boehringer Ingelheim International GmbH
  • Cadwell Industries Inc.
  • Cleveland Medical Devices Inc.
  • Compumedics Limited
  • Drive DeVilbiss Healthcare Inc.
  • Eisai Co., Ltd.
  • Fisher & Paykel Healthcare Corp. Ltd.
  • Koninklijke Philips NV
  • Merck and Co. Inc.
  • Natus Medical Inc.
  • Nihon Kohden Corporation
  • Pfizer Inc.
  • ResMed Inc.
  • Sanofi SA
Product Code: MRR-AD517FAA7863

The Sleep Aids Market was valued at USD 59.32 billion in 2023, expected to reach USD 64.15 billion in 2024, and is projected to grow at a CAGR of 5.98%, to USD 89.11 billion by 2030.

The sleep aids market encompasses a variety of products and services designed to help individuals achieve better sleep. This category includes pharmaceuticals like sedatives and hypnotics, over-the-counter remedies such as melatonin supplements, and devices like smart sleep masks and sleep tracking apps. The necessity for sleep aids arises from the prevalent issues of insomnia, sleep apnea, and other sleep disorders exacerbated by increasingly stressful and fast-paced lifestyles. Their application spans healthcare facilities, wellness centers, and individual use at home. End users include adults struggling with sleep problems, older demographics facing natural sleep decline, and even teenagers affected by screen time. Market growth is driven by increasing awareness of the importance of sleep, rising incidence of sleep disorders, and advancements in sleep technology. However, it's also influenced by the stigma of dependence on sleep medications and concerns about side effects. A significant opportunity lies in natural and alternative sleep solutions like herbal supplements and digital therapeutics, reflecting a public shift toward holistic health practices. Recommendations include investing in research and development of non-addictive sleep aids and user-friendly sleep technology. The market faces challenges such as stringent regulations in pharmaceuticals, variability in user needs, and competition from traditional practices like meditation and yoga. Innovation is ripe in biosensors for more accurate sleep tracking, AI-driven personalized sleep solutions, and integrative apps that combine data from multiple health metrics. The sleep aids market is dynamic, characterized by rapid technological advancements and a strong preference for safe, effective solutions that fit seamlessly into daily life. To capitalize on this evolving landscape, companies should focus on building versatile product lines that cater to a diverse consumer base seeking both medical and non-medical sleep improvement solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 59.32 billion
Estimated Year [2024] USD 64.15 billion
Forecast Year [2030] USD 89.11 billion
CAGR (%) 5.98%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Sleep Aids Market

The Sleep Aids Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for treating & diagnosing different forms of sleep conditions
    • Rising public awareness of the sleep disorders
    • Growing acceptance of wearable sensors and tracking devices
  • Market Restraints
    • Inappropriate calibration of devices of sleeping aids
  • Market Opportunities
    • Introduction of novel technologies in sleeping aids
    • Growing government funding for research & development (R&D) to bid huge sleep aids
  • Market Challenges
    • Absence of appropriate documents for the permitting license

Porter's Five Forces: A Strategic Tool for Navigating the Sleep Aids Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Sleep Aids Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Sleep Aids Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Sleep Aids Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Sleep Aids Market

A detailed market share analysis in the Sleep Aids Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Sleep Aids Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Sleep Aids Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Sleep Aids Market

A strategic analysis of the Sleep Aids Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Sleep Aids Market, highlighting leading vendors and their innovative profiles. These include Apnea Sciences Corporation, Boehringer Ingelheim International GmbH, Cadwell Industries Inc., Cleveland Medical Devices Inc., Compumedics Limited, Drive DeVilbiss Healthcare Inc., Eisai Co., Ltd., Fisher & Paykel Healthcare Corp. Ltd., Koninklijke Philips N. V., Merck and Co. Inc., Natus Medical Inc., Nihon Kohden Corporation, Pfizer Inc., ResMed Inc., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Sleep Aids Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Mattresses & Pillows, Medications, and Sleep Apnea Devices. The Medications is further studied across Herbal Drugs, OTC Drugs, and Prescription-Based Drugs. The Sleep Apnea Devices is further studied across Adaptive Servo-Ventilators (ASVs), Facial Interfaces, Oral Appliances, and Positive Airway Pressure (PAP) Devices.
  • Based on Sleep-Disorder, market is studied across Insomnia, Narcolepsy, Restless Legs Syndrome, Sleep Apnea, and Sleep Walking.
  • Based on Distribution Channel, market is studied across Drug Stores, E-Commerce, Hospital Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for treating & diagnosing different forms of sleep conditions
      • 5.1.1.2. Rising public awareness of the sleep disorders
      • 5.1.1.3. Growing acceptance of wearable sensors and tracking devices
    • 5.1.2. Restraints
      • 5.1.2.1. Inappropriate calibration of devices of sleeping aids
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of novel technologies in sleeping aids
      • 5.1.3.2. Growing government funding for research & development (R&D) to bid huge sleep aids
    • 5.1.4. Challenges
      • 5.1.4.1. Absence of appropriate documents for the permitting license
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Sleep Aids Market, by Product

  • 6.1. Introduction
  • 6.2. Mattresses & Pillows
  • 6.3. Medications
    • 6.3.1. Herbal Drugs
    • 6.3.2. OTC Drugs
    • 6.3.3. Prescription-Based Drugs
  • 6.4. Sleep Apnea Devices
    • 6.4.1. Adaptive Servo-Ventilators (ASVs)
    • 6.4.2. Facial Interfaces
    • 6.4.3. Oral Appliances
    • 6.4.4. Positive Airway Pressure (PAP) Devices

7. Sleep Aids Market, by Sleep-Disorder

  • 7.1. Introduction
  • 7.2. Insomnia
  • 7.3. Narcolepsy
  • 7.4. Restless Legs Syndrome
  • 7.5. Sleep Apnea
  • 7.6. Sleep Walking

8. Sleep Aids Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Drug Stores
  • 8.3. E-Commerce
  • 8.4. Hospital Pharmacies
  • 8.5. Retail Pharmacies

9. Americas Sleep Aids Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Sleep Aids Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Sleep Aids Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Apnea Sciences Corporation
  • 2. Boehringer Ingelheim International GmbH
  • 3. Cadwell Industries Inc.
  • 4. Cleveland Medical Devices Inc.
  • 5. Compumedics Limited
  • 6. Drive DeVilbiss Healthcare Inc.
  • 7. Eisai Co., Ltd.
  • 8. Fisher & Paykel Healthcare Corp. Ltd.
  • 9. Koninklijke Philips N. V.
  • 10. Merck and Co. Inc.
  • 11. Natus Medical Inc.
  • 12. Nihon Kohden Corporation
  • 13. Pfizer Inc.
  • 14. ResMed Inc.
  • 15. Sanofi S.A.

LIST OF FIGURES

  • FIGURE 1. SLEEP AIDS MARKET RESEARCH PROCESS
  • FIGURE 2. SLEEP AIDS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SLEEP AIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SLEEP AIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SLEEP AIDS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SLEEP AIDS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SLEEP AIDS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SLEEP AIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SLEEP AIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SLEEP AIDS MARKET DYNAMICS
  • TABLE 7. GLOBAL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SLEEP AIDS MARKET SIZE, BY MATTRESSES & PILLOWS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SLEEP AIDS MARKET SIZE, BY HERBAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SLEEP AIDS MARKET SIZE, BY OTC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SLEEP AIDS MARKET SIZE, BY PRESCRIPTION-BASED DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SLEEP AIDS MARKET SIZE, BY ADAPTIVE SERVO-VENTILATORS (ASVS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SLEEP AIDS MARKET SIZE, BY FACIAL INTERFACES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SLEEP AIDS MARKET SIZE, BY ORAL APPLIANCES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SLEEP AIDS MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SLEEP AIDS MARKET SIZE, BY INSOMNIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SLEEP AIDS MARKET SIZE, BY NARCOLEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SLEEP AIDS MARKET SIZE, BY RESTLESS LEGS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP WALKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SLEEP AIDS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SLEEP AIDS MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SLEEP AIDS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SLEEP AIDS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 240. SLEEP AIDS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 241. SLEEP AIDS MARKET, FPNV POSITIONING MATRIX, 2023